Advinus has produced four clinical candidates –

• An internal compound for type 2 diabetes that has established PoC in humans.
• A partnered compound for type 2 diabetes undergoing Phase 1 clinical trial in US.
• Two internal compounds for inflammatory diseases in preclinical development stage.

Advinus also has six ongoing internal discovery programs including three programs in candidate selection stage.